Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Journal of Hepatology|May 7, 2008
Mouse models for the study of HCV infection and virus-host interactionsHeidi Barth, Eric Robinet, T Jake Liang, et al.
RSC Advances|September 1, 2020
Synthesis of MeBmt and related derivatives <i>via</i> syn-selective ATH-DKRAdam Rolt, Paul M O'Neill, T Jake Liang, et al.
Journal of Virology|April 14, 2004
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent mannerZhensheng Zhang, Ulrike Protzer, Zongyi Hu, et al.
Gastroenterology|October 4, 2016
Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7Fang Zhang, Catherine Sodroski, Helen Cha, et al.
Journal of Virology|July 2, 2010
Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivoZhensheng Zhang, Eun Sun, Jing-hsiung James Ou, et al.
Journal of Virology|January 22, 2010
Novel function of CD81 in controlling hepatitis C virus replicationYong-Yuan Zhang, Bai-Hua Zhang, Koji Ishii, et al.
Virologica Sinica|November 21, 2018
MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral FactorsCatherine Sodroski, Brianna Lowey, Laura Hertz, et al.
Nature Medicine|May 28, 2013
Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assemblyQisheng Li, Véronique Pène, Siddharth Krishnamurthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?T Jake Liang, Jordan J Feld, Naglaa H Shoukry, et al.
Antiviral Therapy|April 2, 2016
Evaluation of antiviral drug synergy in an infectious HCV systemBilly Lin, Shanshan He, Hyung Joon Yim, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Journal of Hepatology|May 7, 2008
Mouse models for the study of HCV infection and virus-host interactionsHeidi Barth, Eric Robinet, T Jake Liang, et al.
RSC Advances|September 1, 2020
Synthesis of MeBmt and related derivatives <i>via</i> syn-selective ATH-DKRAdam Rolt, Paul M O'Neill, T Jake Liang, et al.
Journal of Virology|April 14, 2004
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent mannerZhensheng Zhang, Ulrike Protzer, Zongyi Hu, et al.
Gastroenterology|October 4, 2016
Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7Fang Zhang, Catherine Sodroski, Helen Cha, et al.
Journal of Virology|July 2, 2010
Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivoZhensheng Zhang, Eun Sun, Jing-hsiung James Ou, et al.
Journal of Virology|January 22, 2010
Novel function of CD81 in controlling hepatitis C virus replicationYong-Yuan Zhang, Bai-Hua Zhang, Koji Ishii, et al.
Virologica Sinica|November 21, 2018
MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral FactorsCatherine Sodroski, Brianna Lowey, Laura Hertz, et al.
Nature Medicine|May 28, 2013
Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assemblyQisheng Li, Véronique Pène, Siddharth Krishnamurthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?T Jake Liang, Jordan J Feld, Naglaa H Shoukry, et al.
Antiviral Therapy|April 2, 2016
Evaluation of antiviral drug synergy in an infectious HCV systemBilly Lin, Shanshan He, Hyung Joon Yim, et al.
Pageof 22